Methotrexate-induced nodulosis, also known as methotrexate-induced accelerated nodulosis (MIAN), is a rare side effect of methotrexate therapy. Methotrexate (MTX) is commonly used to treat various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. In this case series, we present patients with MIAN, discussing their clinical features, diagnostic approaches, and management strategies. We aim to increase recognition of this rare side effect of MTX therapy, facilitate early diagnosis, and improve clinical management, thus minimising the burden of this debilitating complication on affected individuals.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11778614 | PMC |
| http://dx.doi.org/10.31138/mjr.08424.mia | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Methotrexate-Induced Accelerated Nodulosis: A Case Series.
Mediterr J Rheumatol
December 2024
Department of Clinical Immunology and Rheumatology, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, India.
Methotrexate-induced nodulosis, also known as methotrexate-induced accelerated nodulosis (MIAN), is a rare side effect of methotrexate therapy. Methotrexate (MTX) is commonly used to treat various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. In this case series, we present patients with MIAN, discussing their clinical features, diagnostic approaches, and management strategies.
View Article and Find Full Text PDFMethotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus.
Ann Dermatol
November 2023
Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea.
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, flesh-colored nodules on both hands that had developed 3 years ago.
View Article and Find Full Text PDFMethotrexate Pneumonitis After a Low-Dose Medication Error: A Case Report.
Cureus
March 2022
Internal Medicine, Centro Hospitalar Univeristário de São João, Porto, PRT.
Methotrexate is recommended as the first choice of standard drug therapy following the diagnosis of rheumatoid arthritis. Pneumonitis related to methotrexate is a serious, unpredictable adverse event that may become life-threatening. We reported a case of a 68-year-old woman with rheumatoid arthritis that misunderstood the directions for use and took methotrexate daily, instead of weekly, leading to hepatic, hematological, and pulmonary toxicity.
View Article and Find Full Text PDFAllylpyrocatechol attenuates methotrexate-induced hepatotoxicity in a collagen-induced model of arthritis.
Free Radic Res
June 2018
a Department of Pharmacology , Institute of Postgraduate Medical Education and Research, Kolkata , India.
The cornerstone of treatment for rheumatoid arthritis is low dose methotrexate (MTX), but its use is limited by concerns regarding its potential for hepatotoxicity. Allylpyrocatechol (APC), a phytoconstituent sourced from leaves of Piper betle demonstrated antioxidant, anti-inflammatory, and antiarthritic properties. The present study aimed to evaluate the combined effect of APC and MTX on limiting progression of lipopolysaccharide accelerated collagen-induced arthritis, along with reduction of MTX-induced hepatic damage.
View Article and Find Full Text PDFMethotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes.
Drug Chem Toxicol
January 2018
c Faculty of Pharmacy , Shahid Beheshti University of Medical Sciences, Tehran , Iran.
Methotrexate (MTX) is a folic acid antagonist that is widely used to treat a variety of diseases. One of the most serious side effects of MTX therapy is hepatotoxicity. The potential molecular cytotoxic mechanisms of MTX toward isolated rat hepatocytes were investigated using Accelerated Cytotoxicity Mechanism Screening (ACMS) techniques.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!